Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-09-23

Clinical Trial Update: Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of RM-131 in diabetic gastroparesis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • RM-131

Snippet

Sponsor: Motus Therapeutics, Inc. | Conditions: Diabetes Mellitus, Diabetes Mellitus Complications | Phase 2 | Status: COMPLETED